Solid Biosciences SLDB
NASDAQ SLDB
$7.68 +0.51 (+7.04%)
As of: Nov 11, 2026 · 12:00 PM EST

Solid Biosciences (SLDB) Return on Assets [ROA] (2018 - 2026)

Updated

Solid Biosciences (SLDB) recorded Return on Assets [ROA] of -49.11% in Q2 2026, down 1.85 percentage points from -47.25% a year earlier but up 9.41 percentage points from the prior quarter.

Analysis

Solid Biosciences (SLDB) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Solid Biosciences reported Return on Assets [ROA] of -82.78%, down 12.24 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for three straight years, with a five-year change of -18.48 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -70.53% in FY2024 (-25.37 pp), -45.16% in FY2023 (-10.26 pp), -34.91% in FY2022 (+0.87 pp) and -35.78% in FY2021 (+28.52 pp).
  • Quarterly Return on Assets [ROA] has ranged from -68.84% in Q4 2025 to -29.11% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined for seven consecutive quarters, with an average year-over-year change of -6.36 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 171.51 percentage points in Q3 2021, against a drop of 16.41 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -58.52% (Q1 2026), -68.84% (Q4 2025) and -57.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Solid Biosciences 1.08 Bn -212.24 Mn - -53.12%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -53.12%
Jun 30, 2026 -49.11%
Mar 31, 2026 -58.52%
Dec 31, 2025 -68.84%
Sep 30, 2025 -57.42%
Jun 30, 2025 -47.25%
Mar 31, 2025 -52.46%
Dec 31, 2024 -62.27%
Sep 30, 2024 -46.27%
Jun 30, 2024 -37.81%
Mar 31, 2024 -43.64%
Dec 31, 2023 -54.92%
Sep 30, 2023 -46.65%
Jun 30, 2023 -41.56%
Mar 31, 2023 -37.04%
Dec 31, 2022 -38.67%
Sep 30, 2022 -45.52%
Jun 30, 2022 -41.83%
Mar 31, 2022 -36.65%
Dec 31, 2021 -29.99%
API Access

Solid Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SLDB&period=max&api_key=YOUR_API_KEY